Sen. Charles Grassley calls on the Federal Trade Commission to overcome a deadlocked vote and initiate a study into the business practices of pharmacy...
Federal Register notice: FDA makes available a revised draft guidance entitled Verification Systems Under the Drug Supply Chain Security Act for Certa...
FDA issued Zydus Lifesciences (formerly known as Cadila Healthcare) a three-item Form FDA-483 after recently inspecting the firms Jarod, Gujarat (Indi...
Federal Register notice: FDA has announces a 4/21-22 Oncologic Drugs Advisory Committee meeting that will discuss the appropriate approach for phospha...
FDA releases the FDA-483 with four observations issued following an inspection at Annapolis, MD-based Cape Drugs.
AbbVie says it will submit an sNDA to FDA to expand the indication for its Qulipta to include preventive treatment of chronic migraine.
Two Morrison Foerster attorneys describe lessons learned from an Oncologic Drugs Advisory Committee meeting that voted to recommend additional clinica...
The House Energy and Commerce Committee Health Subcommittee announces a 3/17 hearing entitled The Future of Medicine: Legislation to Encourage Innovat...